Cigna Q4 EPS Rises 22% to $8.08 on Evernorth and PBS Strength
Cigna reported fourth-quarter 2025 adjusted EPS of $8.08, a 22% year-over-year increase that exceeded consensus by 2.7%. Growth was fueled by Evernorth Health Services and Pharmacy Benefit Services, while divestitures to Health Care Services Corporation and higher operating expenses weighed on medical customer volumes.
1. Q4 2025 Financial Results
Cigna’s adjusted earnings per share climbed to $8.08 in the fourth quarter of 2025, marking a 22% increase year over year and beating consensus estimates by 2.7%. This performance reflects strong margin management despite headwinds from higher operating costs.
2. Segment Drivers and Headwinds
Evernorth Health Services benefited from new business wins and expanded client relationships, while Pharmacy Benefit Services saw improved specialty drug volumes. Offsetting these gains, divestitures to Health Care Services Corporation reduced medical customer counts and elevated expenses dampened overall profitability.